GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Rightongene Biotechnology Co Ltd (SHSE:688217) » Definitions » EV-to-FCF

Shanghai Rightongene Biotechnology Co (SHSE:688217) EV-to-FCF : 46.95 (As of Apr. 19, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Rightongene Biotechnology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Rightongene Biotechnology Co's Enterprise Value is ¥965.8 Mil. Shanghai Rightongene Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ¥20.6 Mil. Therefore, Shanghai Rightongene Biotechnology Co's EV-to-FCF for today is 46.95.

The historical rank and industry rank for Shanghai Rightongene Biotechnology Co's EV-to-FCF or its related term are showing as below:

SHSE:688217' s EV-to-FCF Range Over the Past 10 Years
Min: -252.13   Med: -41.42   Max: 4201.45
Current: 1039.77

During the past 8 years, the highest EV-to-FCF of Shanghai Rightongene Biotechnology Co was 4201.45. The lowest was -252.13. And the median was -41.42.

SHSE:688217's EV-to-FCF is ranked worse than
98.24% of 454 companies
in the Biotechnology industry
Industry Median: 2.05 vs SHSE:688217: 1039.77

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-19), Shanghai Rightongene Biotechnology Co's stock price is ¥20.03. Shanghai Rightongene Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥-0.280. Therefore, Shanghai Rightongene Biotechnology Co's PE Ratio (TTM) for today is At Loss.


Shanghai Rightongene Biotechnology Co EV-to-FCF Historical Data

The historical data trend for Shanghai Rightongene Biotechnology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rightongene Biotechnology Co EV-to-FCF Chart

Shanghai Rightongene Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial - -211.79 -51.26 -28.35 40.73

Shanghai Rightongene Biotechnology Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -28.35 -24.27 -84.98 899.24 -

Competitive Comparison of Shanghai Rightongene Biotechnology Co's EV-to-FCF

For the Biotechnology subindustry, Shanghai Rightongene Biotechnology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rightongene Biotechnology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Rightongene Biotechnology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Rightongene Biotechnology Co's EV-to-FCF falls into.


;
;

Shanghai Rightongene Biotechnology Co EV-to-FCF Calculation

Shanghai Rightongene Biotechnology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=965.810/20.57
=46.95

Shanghai Rightongene Biotechnology Co's current Enterprise Value is ¥965.8 Mil.
Shanghai Rightongene Biotechnology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥20.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rightongene Biotechnology Co  (SHSE:688217) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Rightongene Biotechnology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.03/-0.280
=At Loss

Shanghai Rightongene Biotechnology Co's share price for today is ¥20.03.
Shanghai Rightongene Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.280.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Rightongene Biotechnology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Rightongene Biotechnology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rightongene Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6055, Jinhai Road, Building 3, Fengxian District, Shanghai, CHN, 201499
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
Executives
Ke Zhong He Core technical personnel

Shanghai Rightongene Biotechnology Co Headlines

No Headlines